Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes
Clinical trial NCT04671043 · COMPLETED
Trial details
- NCT number
- NCT04671043
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-04
- Primary completion
- 2023-02-02
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.